73 DAFTAR PUSTAKA 1. Perhimpunan Dokter Paru Indonesia ...

73

DAFTAR PUSTAKA

1. Perhimpunan Dokter Paru Indonesia. Pneumonia Komuniti: Pedoman

Diagnosis dan Penatalaksanaan di Indonesia. Jakarta: Balai Penerbit

FKUI; 2003.

2. Foy HM, Cooney MK, Allan I, et al. Rates of pneumonia during influenza

epidemics in Seattle, 1964 to 1975. JAMA 1979;241:253-8.

3. American Thoracic Society Board of Directors. Guidelines for the

management of adult with community-acquired pneumonia. Am J Respir

Crit Care Med. 2001; 163:1730-54.

4. Mendel LA, Wuderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean

NC, Dowell SF, et all. Infectious disease society of america / american

thoracic society consensus guidelines on the management of community-

acquired pneumonia in adults. Clinical Infectious Disease. 2007;44:527-

72.

5. Ewig S, Welte T. Evaluation of guidelines for community-acquired

pneumonia: a story of confounders, surprises and challenges. Eur Respir J.

2008;32:823-5.

6. Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ.

Practice guidelines for the management of community-acquired

pneumonia in adults. Infectious Diseases Society of America. Clin Infect

Dis. 2000;31:347-382.

74

7. Sectish TC, Prober CG. Pneumonia. Dalam Behrman RE, Kliegman RM,

Jenson HB. Penyunting Nelson. Textbook of pediatrics. Edisi ke-18

Philadelphia: WB Saunders. 2007;1795-800.

8. Suryanto A. Guideline on the management of severe community acquired

pneumonia and hospital acquired pneumonia. Dalam: Rahmatullah P,

Gasem H, Suntoko B, Purwoko Y, ed. Naskah lengkap chest and critical

care in internal medicine the second national scientific meeting of perpari

and the tenth national congress of perpari. Badan Penerbit Universitas

Diponegoro Semarang. 2008:69-80.

9. Gyssen IC, Van der Broek PJ. Optimizing antimicrobial therapy, a method

for antimicrobial drug use evaluation. J Antimicrob Chemother. 1992;

32:724-7.

10. Kristiyanto, Yusuf; Sianipar, Osman; Hisyam, Barmawi. Etiologi dan

sensitivitas terhadap antibiotik pada pasien pneumonia didapat di

masyarakat. Berkala Kesehatan Klinik vol. 11 no. 2. 2005: halaman 77.

11. Riquelme O R, Riquelme O M, Rioseco Z ML, et all. Etiology and

prognostics factors of community-acquired pneumonia among adults

patients admitted to a regional hospital in Chile. Rev Med Chil. 2006

May;134(5):597-605.

12. Charles PG, Whitby M, Fuller AJ, et all. The etiology of community-

acquired pneumonia in Australia: why penicillin plus doxycycline or a

macrolide is the most appropriate therapy. Clin Infect Dis. 2008 May

15;46(10):1513-21.

75

13. Goto H, Takeda H, Kawai S, et all. Susceptibilities of bacteria isolated

from patients with lower respiratory infectious diseases to antibiotics. Jpn

J Antibiot. 2008 Aug;61(4):209-40.

14. Liu Y, Chen M, Zhao T, et all. Causative agent distribution and antibiotic

therapy assessment among adult patients with community acquired

pneumonia in Chinese urban population. BMC Infect Dis. 2009 Mar

18;9:31.

15. Köksal I, Ozlü T, Bayraktar O, et all. Etiological agents of community-

acquired pneumonia in adult patients in Turkey. Tuberk Toraks.

2010;58(2):119-27.

16. Bao Z, Yuan X, Wang L, et all. The incidence and etiology of community-

acquired pneumonia in fever outpatients. Exp Biol Med (Maywood). 2012

Nov;237(11):1256-61.

17. Tao LL, Hu BJ, He LX, et all. Etiology and antimicrobial resistance of

community-acquired pneumonia in adult patients in China. Chin Med J

(Engl). 2012 Sep;125(17):2967-72.

18. Rahmatullah P. Pengelolaan Pneumoni Komunitas. Dalam: Padmomartono

FM, SUharti C, Gasem MH. Editors. Pertemuan Ilmiah Tahun VI PAPDI

Cabang Semarang. Badan Penerbit Universitas Diponegoro Semarang.

2002: 47-58

19. Rabbat A, Huchon GJ. Bacterial Pneumonia. Dalam: Albert RK, Spiro SG,

Jett JR, Clinical Respiratory Medicine, second edition. Ontario: Mosby.

2004; 23:273-287

76

20. Prasad R, Sanjay. Community Acquired Pneumonia: Evidence Based

Management. Pulmon. 2007; 9:1:4-12.

21. Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C.

Infectious Diseases Society of America. Update of practice guidelines for

the management of community-acquired pneumonia in immunocompetent

adults. Clin Infect Dis. 2003; 37: 1405-1433

22. Niederman MS, Mandell LA, Anzueto A, Bass, JB, Broughton WA,

Campbell GD, et al; American Thoracic Society. Guidelines for the

management of adults with community-acquired pneumonia: Diagnosis,

assessment of severity, antimicrobial therapy, and prevention. Am J Respir

Crit Care Med. 2001; 163: 1730-1754

23. Holmes CL, Russel JA, Walley KR. Genetic polymorphism in sepsis and

septic shock. Chest 2003;124:1103-1115.

24. W S Lim, S V Baudouin, R C George, et all. BTS guidelines for the

management of community acquired pneumonia in adults: update 2009.

Thorax. 2009; 64: iii1-iii55

25. Mandell LA. Pneumonia, In : Fauci AS, Kasper DL, Longo DL, eds,

Harrison’s Principles of Internal Medicine, 17th ed, USA, The Mc Graw-

Hill companies Inc. 2008; chapter 251.

26. Sharpe BA, Flanders SA. Community Acquired Pneumonia: A practical

approach to management for hospital. Journal of Hospital Medicine vol 1,

no 3. 2006; 177-190

77

27. Handoyo, Thomas. Pneumonia severity index (PSI), CRB-65, dan CURB-

65 Untuk Memprediksi Ketahanan Hidup-30 Hari dan Mortalitas-30 Hari

Pada Penderita Community-acquired pneumonia (CAP) di RSUP dokter

Kariadi Semarang dan RSU Ketileng Kotamadia Semarang. Semarang:

Universitas Diponegoro. 2010.

28. Niederman MS. Pneumonia, Including Community-Acquired Pneumonia

and Nosocomial Pneumonia. In Crapo JD, Glassroth J, Karlinsky, King Jr.

TE, editors. Baum’s Textbook of Pulmonary Disease. Seventh Ed.

Lippincot Williams and Wilkins. 2004; 22:425-453.

29. Marrie TJ, Campbell GD, Walker DH, Low DE. Pneumonia. In: Kasper D,

Fauci A, Longo DL, Braunwald E, Hauser SL, Jameson JL, editors.

Harrison’s principle of internal medicine 16th. New York-Toronto: Mc

Graw Hill Health Profession Division; 2005. P 1528-38

30. Marston BJ, Plouffe JF, File TM Jr, et al.Incidence of community-acquired

pneumonia requiring hospitalization: results of a population-based active

surveillance study in Ohio. Arch Intern Med. 1997;157:1709-18

31. Amrita. Evaluasi Penggunaan Antibiotik Empirik pada Penderita

Community-acquired pneumonia (CAP) yang Dirawat di RSUP dokter

Kariadi Semarang. Semarang: Universitas Diponegoro. 2010

32. Pedoman Penggunaan Antibiotik RSUP Dokter Kariadi (2007)

33. Dagnew Mulat, Yismaw Gizachew, et all. Bacterial profile and

antimicrobial susceptibility pattern in septicemia suspected patients

78

attending Gondar University Hospital, Northwest Ethiopia. BMC Research

Notes. 2013, 6:283

34. Cham Gregory, Yan Sun, et all. Predicting Positive Blood Cultures in

Patients presenting with Pneumonia at an Emergency Department in

Singapore. Annals Academy of Medicine. 2009 June; Vol 38 No. 6

35. Hartzell Joshua D, Kim Andrew S, et all. Acinetobacter Pneumonia: A

Review. MedGen Med. 2007 Jul; 9(3): 4

36. Wilks David, Farrington Mark. The Infectious Disease Manual. Oxford:

Blackwell Science. 1995

37. Erdede M, Denizbasi A, Onur O, et all. Do we really need blood cultures

in treating patients with community-acquired pneumonia. Bratisi Lek Listy

2010; 111 (5):286-289

38. Froggat JW, Johnston JL, Galetto DW, et all. Antimicrobial resistance in

nosocomial isolates of Staphylococcus haemolyticus. Antimicrob Agents

Chemother. 1989; 33 (4): 460-6

39. Wojtyczka Robert D, Orlewaska Kamila, et all. Biofilm Formation and

Antimicrobial Susceptibility of Staphylococcus epidermidis Strains from

Hospital Environment. Int. J. Environ. Res. Pubic Health. 2014, 11, 4619-

4633

40. Afshar Nima, Tabas Jeffrey, et all. Blood Cultures for Community

Acquired Pneumonia: Are They Worthy of Two Quality Measures? A

Systematic Review. Society of Hospital Medicine. 2009 February. Vol 4

no.2

79

41. TJ Marrie, M Poulin-Costello, et all. Etiology of community-acquired

pneumonia treated in an ambulatory setting. Respir Med. 2005 Jan;

99(1):60-5.

42. Mohsenifar Z, Chopra Sawtantra K, et all. Candida Pneumonia-Experience

With 20 Patients. West J Med. 1979 Sep;131:196-200

43. Freitas M, Castelo A, et all. Viridans streptococci causing community

acquired pneumonia. Arch Dis Child. Sep 2006; 91(9): 779-780

44. Eugenin Eliseo A. Community-acquired pneumonia infections by

Acinetobacter baumanii-How does alcohol impact the antimicrobial

functions of macrophages. Landes Bioscience. August 2013. Virulence

4:6, 435-436.

45. TJ Marrie, et all. Community-acquired pneumonia due to eschericia coli.

Clin Microbiol Infect. 1998 Feb; 4(12):717-723

46. Boyer Alexandre, Amadeo Brice, et all. Severe community-acquired

Enterobacter pneumonia: a plea for greater awareness of the concept of

health care associated pneumonia. BMC Infectious Diseases. 2011, 11:120

47. F Gantier, et all. Two cases of severe community-acquired pleural

pneumonia due to Streptococcus pyogenes. Press Med. 2003 May 24;

32(18): 839-42

80

48. Teng Lee-Jene, Yuan Ang, et all. Clinical and Microbiological

Characteristics of Rhizobium radiobacter Infections. Clinical Infectious

Disease. 2004; 149-53

49. MR Monteen, et all. Treatment of Chryseobacterium indolgenes

ventilator-associated pneumonia in a critically ill trauma patients. Ann

Pharmacother. 2013 Dec; 47(12): 1736-9

50. Leesik H, Ani U, Juhani A, et all. Microbial pathogens of adult community

acquired pneumonia in Southern Estonia. Medicina (Kaunas). 2006;

42(5):384-94.

51. Banu Asima, Kabbin Jyoti S, et all. Extraintestinal Infections due to

Escherichia coli: An emerging Issue. Journal of Clinical Diagnostic

Research. 2011 June. Vol 5(3); 486-490

52. I Reynauld, et all. A severe form of Chryseobacterium indolgenes

pneumonia in an immunocompetent patient. Med Mal Infect. 2007 Nov;

37(11):762-4

81

Lampiran 1. Ethical Clearance

82

Lampiran 2. Surat permohonan peminjaman rekam medik

83

Lampiran 3. Daftar tilik penelusuran rekam medik

Nama

Usia

Jenis Kelamin

No. CM

Spesimen

Metode

Kuman

sensitivitas antibiotik S / R

amikacin

amoxiclav AC

ampicil-sulbactam

cefepime

cefotaxime

cefoxitin

ciprofloxacin

chloramphenicol

cotrimoxazole

erythromycin

meropenem

moxifloxacin

piper + tazobactam

tetracyclin

sulbactam cefoperazone

ceftazidime

84

Lampiran 4. Dokumentasi penelitian

85

Lampiran 5. Biodata Mahasiswa

Identitas

Nama : Marcellinus Triyuono Dairo

NIM : 22010110120134

Tempat / tanggal lahir : Cirebon, 11 Januari 1992

Jenis Kelamin : Laki-laki

Alamat : Jl. Simega no.111 Kabupaten Cirebon, Jawa Barat

Nomor HP : 083878566383

E-mail : [email protected]

Riwayat Pendidikan Formal

1. SD Santa Maria Cirebon : 1998 - 2004

2. SMP Santa Maria Cirebon : 2004 - 2007

3. SMA Negeri 1 Kota Cirebon : 2007 - 2010

4. Fakultas Kedokteran Undip : 2010 -

Keanggotan Organisasi

1. BEM Kastrad Fakultas Kedokteran-Kedokteran Umum Undip tahun 2010